Tatva Chintan Pharma Chem (NSE:TATVA) Beta: 1.6873 (As of Jun. 30, 2026)


NSE:TATVA Tatva Chintan Pharma Chem Ltd NSE:TATVA
81 GF Score
Price ₹1,196.00
GF Value ₹1,453.22
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Tatva Chintan Pharma Chem Beta?

Tatva Chintan Pharma Chem NSE:TATVA +1.30% 81 Beta is 1.6873 as of Jun. 30, 2026. GuruFocus rates NSE:TATVA with a GF Score™ of 81/100 and a GF Value™ of ₹1,453.22 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-30), Tatva Chintan Pharma Chem's Beta is 1.6873.


Tatva Chintan Pharma Chem  (NSE:TATVA) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Tatva Chintan Pharma Chem Beta Related Terms


Tatva Chintan Pharma Chem Beta Historical Data

* Premium members only.

The historical data trend for Tatva Chintan Pharma Chem's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tatva Chintan Pharma Chem Beta Chart

Tatva Chintan Pharma Chem Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial 0.00 0.00 0.00 0.70 1.43

Tatva Chintan Pharma Chem Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.70 0.97 0.94 1.58 1.43

NSE:TATVA vs LIN, SHW, ECL: Beta Comparison

For the Specialty Chemicals subindustry, Tatva Chintan Pharma Chem's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tatva Chintan Pharma Chem Beta vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Tatva Chintan Pharma Chem's Beta distribution charts can be found below:

* The bar in red indicates where Tatva Chintan Pharma Chem's Beta falls into.


NSE:TATVA
81GF Score
Tatva Chintan Pharma Chem Ltd NSE:TATVA
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tatva Chintan Pharma Chem Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.6873 mean?
Tatva Chintan Pharma Chem (NSE:TATVA) has a Beta of 1.6873 as of Jun. 30, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Tatva Chintan Pharma Chem and its competitors.
Is Tatva Chintan Pharma Chem's Beta too high?
Tatva Chintan Pharma Chem's current Beta is 1.6873. Overall, Tatva Chintan Pharma Chem has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tatva Chintan Pharma Chem's Beta compare to LIN and SHW?
Tatva Chintan Pharma Chem's Beta of 1.6873 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Chemicals company?
A good Beta depends on the Chemicals industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Tatva Chintan Pharma Chem and its competitors. Tatva Chintan Pharma Chem's current Beta is 1.6873. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tatva Chintan Pharma Chem stock overvalued right now?
Based on GuruFocus' analysis, Tatva Chintan Pharma Chem (NSE:TATVA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,453.22, compared to a current price of ₹1,196.00 — trading 17.7% below its estimated fair value. The current Beta is 1.6873. Tatva Chintan Pharma Chem's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Tatva Chintan Pharma Chem (NSE:TATVA), the current Beta is 1.6873 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tatva Chintan Pharma Chem (NSE:TATVA) Overvalued in 2026?

Based on GuruFocus' analysis, Tatva Chintan Pharma Chem stock appears to be undervalued. The current stock price of ₹1,196.00 is trading 17.7% below its estimated GF Value™ of ₹1,453.22. GuruFocus considers Tatva Chintan Pharma Chem to be Modestly Undervalued.

Key valuation signals for NSE:TATVA:

  • Beta: 1.6873
  • GF Value™: ₹1,453.22 vs. price of ₹1,196.00 (17.7% below fair value)
  • GF Score™: 81/100 with 3 warning signs

No single metric tells the full story. See the NSE:TATVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tatva Chintan Pharma Chem Business Description

Other Exchanges 543321:India
Address Plot No. 353, Makarpura GIDC, Vadodara, GJ, IND, 390010
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.
81GF Score

Get the complete analysis for NSE:TATVA

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,196.00
Price
₹1,453.22
GF Value